Dehydration-induced vasopressin secretion in humans: involvement of the histaminergic system.
In rats, the hypothalamic neurotransmitter histamine participates in regulation of vasopressin secretion and seems to be of physiological importance, because blockade of the histaminergic system reduces dehydration-induced vasopressin secretion. We investigated whether histamine is also involved in regulation of vasopressin secretion during dehydration in humans. We found that 40 h of dehydration gradually increased plasma osmolality by 10 mosmol/kg and induced a fourfold increase in vasopressin levels. Pretreatment with the H(2)-receptor antagonists cimetidine or ranitidine significantly reduced the dehydration-induced increase in vasopressin levels approximately 40% after 34 and 37 h of dehydration, whereas this was not the case with the H(1)-receptor antagonist mepyramine. Dehydration reduced aldosterone secretion by approximately 50%. This effect of dehydration was reduced by both H(1)- and H(2)-receptor blockade after 16 and/or 34 h of dehydration. We conclude that vasopressin secretion in response to dehydration in humans is under the regulatory influence of histamine and that the effect seems to be mediated via H(2)-receptors. In addition, the regulation of aldosterone secretion during dehydration also seems to involve the histaminergic system via H(1) and H(2) receptors.
Kjaer
A
A
Department of Medical Physiology, Division of Endocrinology and Metabolism, The Panum Institute, Rigshospitalet, University of Copenhagen, DK-2200 Copenhagen N, Denmark. kjaer@mfi.ku.dk
Knigge
U
U
Jørgensen
H
H
Warberg
J
J
D000328:Adult; D000450:Aldosterone / Q000378:metabolism; D002927:Cimetidine / Q000008:administration & dosage; D018592:Cross-Over Studies; D003681:Dehydration / Q000378:metabolism*; D004311:Double-Blind Method; D006634:Histamine H1 Antagonists / Q000008:administration & dosage; D006635:Histamine H2 Antagonists / Q000008:administration & dosage; D006801:Humans; D008297:Male; D009994:Osmolar Concentration; D010919:Placebos; D011738:Pyrilamine / Q000008:administration & dosage; D011899:Ranitidine / Q000008:administration & dosage; D011969:Receptors, Histamine H1 / Q000378:metabolism*; D011970:Receptors, Histamine H2 / Q000378:metabolism*; D014667:Vasopressins / Q000378:metabolism*; D014882:Water-Electrolyte Balance / Q000187:drug effects / Q000502:physiology
D006634:Histamine H1 Antagonists; D006635:Histamine H2 Antagonists; D010919:Placebos; D011969:Receptors, Histamine H1; D011970:Receptors, Histamine H2; D014667:Vasopressins; D000450:Aldosterone; D002927:Cimetidine; D011899:Ranitidine; D011738:Pyrilamine